288 related articles for article (PubMed ID: 28700671)
1. A case-control study on association of proteasome subunit beta 8 (PSMB8) and transporter associated with antigen processing 1 (TAP1) polymorphisms and their transcript levels in vitiligo from Gujarat.
Jadeja SD; Mansuri MS; Singh M; Dwivedi M; Laddha NC; Begum R
PLoS One; 2017; 12(7):e0180958. PubMed ID: 28700671
[TBL] [Abstract][Full Text] [Related]
2. Association and expression of the antigen-processing gene PSMB8, coding for low-molecular-mass protease 7, with vitiligo in North India: case-control study.
Dani P; Patnaik N; Singh A; Jaiswal A; Agrawal B; Kumar AA; Varkhande SR; Sharma A; Vaish U; Ghosh P; Sharma VK; Sharma P; Verma G; Kar HK; Gupta S; Natarajan VT; Gokhale RS; Rani R
Br J Dermatol; 2018 Feb; 178(2):482-491. PubMed ID: 28207947
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-4 genetic variants correlate with its transcript and protein levels in patients with vitiligo.
Imran M; Laddha NC; Dwivedi M; Mansuri MS; Singh J; Rani R; Gokhale RS; Sharma VK; Marfatia YS; Begum R
Br J Dermatol; 2012 Aug; 167(2):314-23. PubMed ID: 22512783
[TBL] [Abstract][Full Text] [Related]
4. Association of elevated homocysteine levels and Methylenetetrahydrofolate reductase (MTHFR) 1298 A > C polymorphism with Vitiligo susceptibility in Gujarat.
Jadeja SD; Mansuri MS; Singh M; Patel H; Marfatia YS; Begum R
J Dermatol Sci; 2018 May; 90(2):112-122. PubMed ID: 29395581
[TBL] [Abstract][Full Text] [Related]
5. Association of NLRP1 genetic variants and mRNA overexpression with generalized vitiligo and disease activity in a Gujarat population.
Dwivedi M; Laddha NC; Mansuri MS; Marfatia YS; Begum R
Br J Dermatol; 2013 Nov; 169(5):1114-25. PubMed ID: 23773036
[TBL] [Abstract][Full Text] [Related]
6. Association Analysis of Proteasome Subunits and Transporter Associated with Antigen Processing on Chinese Patients with Parkinson's Disease.
Mo MS; Huang W; Sun CC; Zhang LM; Cen L; Xiao YS; Li GF; Yang XL; Qu SG; Xu PY
Chin Med J (Engl); 2016 May; 129(9):1053-8. PubMed ID: 27098790
[TBL] [Abstract][Full Text] [Related]
7. Association of FOXP3 and GAGE10 promoter polymorphisms and decreased FOXP3 expression in regulatory T cells with susceptibility to generalized vitiligo in Gujarat population.
Giri PS; Patel S; Begum R; Dwivedi M
Gene; 2021 Feb; 768():145295. PubMed ID: 33181260
[TBL] [Abstract][Full Text] [Related]
8. Association of neuropeptide Y (NPY), interleukin-1B (IL1B) genetic variants and correlation of IL1B transcript levels with vitiligo susceptibility.
Laddha NC; Dwivedi M; Mansuri MS; Singh M; Patel HH; Agarwal N; Shah AM; Begum R
PLoS One; 2014; 9(9):e107020. PubMed ID: 25221996
[TBL] [Abstract][Full Text] [Related]
9. Transporter TAP1-637G and immunoproteasome PSMB9-60H variants influence the risk of developing vitiligo in the Saudi population.
Elhawary NA; Bogari N; Jiffri EH; Rashad M; Fatani A; Tayeb M
Dis Markers; 2014; 2014():260732. PubMed ID: 25548428
[TBL] [Abstract][Full Text] [Related]
10. The catalase gene promoter and 5'-untranslated region variants lead to altered gene expression and enzyme activity in vitiligo.
Mansuri MS; Jadeja SD; Singh M; Laddha NC; Dwivedi M; Begum R
Br J Dermatol; 2017 Dec; 177(6):1590-1600. PubMed ID: 28542879
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms of proteasome subunit genes of the MHC-I antigen-presenting system are associated with cervical cancer in a Chinese Han population.
Li C; Dai S; Yan Z; Zhang X; Liu S; Wang X; Wang J; Shi L; Yao Y
Hum Immunol; 2020 Aug; 81(8):445-451. PubMed ID: 32684411
[TBL] [Abstract][Full Text] [Related]
12. Is the +405 G/C single nucleotide polymorphism of the vascular endothelial growth factor (VEGF) gene associated with late-onset vitiligo?
Almasi-Nasrabadi M; Amoli MM; Robati RM; Rajabi F; Parichehreh Dizaji S
Int J Immunogenet; 2019 Aug; 46(4):241-246. PubMed ID: 31135085
[TBL] [Abstract][Full Text] [Related]
13. Association of TAP1 and TAP2 Gene Polymorphisms with Susceptibility to Pulmonary Tuberculosis.
Naderi M; Hashemi M; Amininia S
Iran J Allergy Asthma Immunol; 2016 Feb; 15(1):62-8. PubMed ID: 26996113
[TBL] [Abstract][Full Text] [Related]
14. Variations in
Mufti AH; AlJahdali IA; Elhawary NA; Ekram SN; Abumansour I; Sindi IA; Naffadi H; Elhawary EN; Alyamani NM; Alghamdi G; Alosaimi W; Rawas G; Alharbi A; Tayeb MT
Int J Gen Med; 2021; 14():10031-10044. PubMed ID: 34984025
[TBL] [Abstract][Full Text] [Related]
15. Elevated X-Box Binding Protein1 Splicing and Interleukin-17A Expression Are Associated With Active Generalized Vitiligo in Gujarat Population.
Jadeja SD; Vaishnav J; Bharti AH; Begum R
Front Immunol; 2021; 12():801724. PubMed ID: 35046957
[TBL] [Abstract][Full Text] [Related]
16. PSMB8 (LMP7) but not PSMB9 (LMP2) gene polymorphisms are associated to pigeon breeder's hypersensitivity pneumonitis.
Camarena A; Aquino-Galvez A; Falfán-Valencia R; Sánchez G; Montaño M; Ramos C; Juárez A; García-de-Alba C; Granados J; Selman M
Respir Med; 2010 Jun; 104(6):889-94. PubMed ID: 20153157
[TBL] [Abstract][Full Text] [Related]
17. Catalase -262C>T polymorphisms in Hungarian vitiligo patients and in controls: further acatalasemia mutations in Hungary.
Kósa Z; Fejes Z; Nagy T; Csordás M; Simics E; Remenyik E; Góth L
Mol Biol Rep; 2012 Apr; 39(4):4787-95. PubMed ID: 21947853
[TBL] [Abstract][Full Text] [Related]
18. The association between endothelin-1 gene polymorphisms and susceptibility to vitiligo in a Korean population.
Kim HJ; Choi CP; Uhm YK; Kim YI; Lee JW; Yoon SH; Chung JH; Lee MH
Exp Dermatol; 2007 Jul; 16(7):561-6. PubMed ID: 17576235
[TBL] [Abstract][Full Text] [Related]
19. CDH1 and DDR1 common variants confer risk to vitiligo and autoimmune comorbidities.
Almasi-Nasrabadi M; Amoli MM; Robati RM; Rajabi F; Ghalamkarpour F; Gauthier Y
Gene; 2019 Jun; 700():17-22. PubMed ID: 30890477
[TBL] [Abstract][Full Text] [Related]
20. Association of interleukin 1 receptor antagonist intron 2 variable number of tandem repeats polymorphism with vitiligo susceptibility in Gujarat population.
Singh M; Mansuri MS; Jadeja SD; Marfatia YS; Begum R
Indian J Dermatol Venereol Leprol; 2018; 84(3):285-291. PubMed ID: 29620037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
